









Markets
/
Stocks
/
nasdaq-bfrg
/

BullFrog AI Holdings, Inc.

BFRG

0.571USD

+0.071+14.20%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

5.95MMarket Cap

LossP/E TTM



BullFrog AI Holdings, Inc.

0.571

+0.071+14.20%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of BullFrog AI Holdings, Inc.

Currency: USD Updated: 2026-02-06

Key Insights

BullFrog AI Holdings, Inc.'s fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 211 out of 392 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

BullFrog AI Holdings, Inc.'s Score

Industry at a Glance

Industry Ranking

211 / 392

Overall Ranking

425 / 4521

Industry

Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

BullFrog AI Holdings, Inc. Highlights

StrengthsRisks

Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 0.00.

Overvalued

The company’s latest PE is -0.83, at a high 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 157.46K shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of BullFrog AI Holdings, Inc. is 7.64, ranking 90 out of 392 in the Biotechnology & Medical Research industry. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

7.64

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.66

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

3.09

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.48

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

BullFrog AI Holdings, Inc.'s Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of BullFrog AI Holdings, Inc. is 8.05, ranking 67 out of 392 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.83, which is -100.00% below the recent high of 0.00 and -1557.97% above the recent low of -13.78.

Score

Industry at a Glance

Previous score

8.05

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 211/392

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for BullFrog AI Holdings, Inc.. The Biotechnology & Medical Research industry's average is 8.05.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of BullFrog AI Holdings, Inc. is 5.29, ranking 324 out of 392 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 0.78 and the support level at 0.43, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.04

Change

0.25

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.013

Sell

RSI(14)

36.129

Neutral

STOCH(KDJ)(9,3,3)

16.391

Neutral

ATR(14)

0.078

High Vlolatility

CCI(14)

-96.877

Neutral

Williams %R

75.485

Sell

TRIX(12,20)

-1.705

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

0.556

Buy

MA10

0.615

Sell

MA20

0.672

Sell

MA50

0.874

Sell

MA100

1.077

Sell

MA200

1.310

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of BullFrog AI Holdings, Inc. is 3.00, ranking 197 out of 392 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 10.58%, representing a quarter-over-quarter decrease of 8.88%. The largest institutional shareholder is The Vanguard, holding a total of 157.46K shares, representing 1.38% of shares outstanding, with 14.24% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Singh (Vininder)

2.37M

+3.27%

Tivoli Trust

715.76K

-9.31%

The Vanguard Group, Inc.

Star Investors

151.20K

-0.20%

Anson Funds Management LP.

80.75K

Geode Capital Management, L.L.C.

55.62K

Fortem Financial Group, LLC

50.00K

Susquehanna International Group, LLP

19.43K

+30.19%

UBS Financial Services, Inc.

7.09K

+449.15%

Citadel Advisors LLC

15.03K

Raymond James & Associates, Inc.

15.00K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Biotechnology & Medical Research domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of BullFrog AI Holdings, Inc. is 1.73, ranking 287 out of 392 in the Biotechnology & Medical Research industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.